News Industry News Regado Biosciences, Inc. Presents Positive Efficacy and Safety Substudy Data from the Phase 2b RADAR Trial for the REG1 Anticoagulation System November 06, 2011
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011
News Daily News Dabigatran Recommended as Alternative to Warfarin in A-fib Patients Jason Kahn February 13, 2011